Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The ID1 protein, an inhibitor of basic helix-loop-helix transcription factors, has been involved in multiple cellular processes including cell cycle regulation, apoptosis, and angiogenesis. To evaluate the importance of ID1 in malignant melanoma, tumour cell expression was examined by immunohistochemistry in 119 cases of nodular melanoma using tissue microarray technique, and related to multiple tumour markers including proliferation, p16 expression, angiogenesis and patient survival. Strong ID1 expression was significantly associated with increased tumour thickness, and significantly reduced survival. Also, increased ID1 was associated with loss of thrombospondin-1 (TSP-1) expression, a known inhibitor of angiogenesis, and increased intensity of ephrin-A1 and its receptor EPHA2. Presence of BRAF mutations was related to strong ID1 expression, but there was no relationship with p16 protein expression. Further, no significant correlation was found between ID1 and microvessel density. In conclusion, our study supports a significant role of the ID1 protein in melanoma progression and patient prognosis. The absence of correlation with p16 protein expression and angiogenesis suggests that other regulatory pathways and mechanisms might be influenced by ID1 in melanomas. An inverse relation between ID1 and TSP-1 expression support an important role of ID1 in the regulation of this complex multitarget protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upregulation of EphA2 occurs in several cancers such as melanoma [157], ovarian [158, 159], prostate [160, 161], lung [162, 163], and breast [164, 165] cancer.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“Id proteins were shown to influence VEGF-dependent mobilisation of circulating endothelial cells and endothelial precursor cells from the bone marrow (Lyden et al, 2001).”
BackgroundId1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., Manova, K., et al. (1999) · Nature · doi:10.1038/44334 · Cited by 922
Aas, T., Børresen, A.-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., & Lønning, P. E. (1996) · Nature Medicine · doi:10.1038/nm0796-811 · Cited by 736
Self-citationRegulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Norušis, M. J. (1994) · Medical Entomology and Zoology · Cited by 699
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
Ohtani, N., Zebedee, Z., Huot, T. J. G., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G., & Hara, E. (2001) · Nature · doi:10.1038/35059131 · Cited by 654 · cited 4×
“The specificity of both antibodies has been reported (Hollnagel et al, 1999; Nickoloff et al, 2000; Ohtani et al, 2001;Czuwara-Ladykowska et al, 2002; Chambers et al, 2003).”
BackgroundInfluentialId Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells
Hollnagel, A., Oehlmann, V., Heymer, J., Rüther, U., & Nordheim, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19838 · Cited by 527
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
Rocco, J. W., & Sidransky, D. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5149 · Cited by 470
Id helix—loop—helix proteins in cell growth and differentiation
Norton, J. D., Deed, R. W., Craggs, G., & Sablitzky, F. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)80013-5 · Cited by 410
Hoos, A., Urist, M. J., Stojadinovic, A., Mastorides, S., Dudas, M. E., Leung, D. H. Y., Kuo, D., Brennan, M. F., Lewis, J. J., & Cordon-Cardo, C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64075-8 · Cited by 400
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Nocito, A., Bubendorf, L., Tinner, E. M., Süess, K., Wagner, U., Forster, T., Kononen, J., Fijan, A., Bruderer, J., Schmid, U., et al. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200107)194:3<349::aid-path887>3.0.co;2-d · Cited by 317
Lin, C. Q., Singh, J., Murata, K., Itahana, Y., Parrinello, S., Liang, S. H., Gillett, C., Campisi, J., & Desprez, P. Y. (2000) · PubMed · Cited by 257
Chambers, R. C., Leoni, P., Kaminski, N., Laurent, G. J., & Heller, R. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63847-3 · Cited by 255
Id2 Specifically Alters Regulation of the Cell Cycle by Tumor Suppressor Proteins
Lasorella, A., Iavarone, A., & Israel, M. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2570 · Cited by 241
Straume, O., Sviland, L., & Akslen, L. A. (2000) · PubMed · Cited by 238
Self-citationId1 regulation of cellular senescence through transcriptional repression of p16/Ink4a
Alani, R. M., Young, A. Z., & Shifflett, C. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141235398 · Cited by 227
Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1
Volpert, O. V., Pili, R., Sikder, H. A., Nelius, T., Zaichuk, T., Morris, C., Shiflett, C. B., Devlin, M. K., Conant, K., & Alani, R. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00209-x · Cited by 190
Coupling of Cell Growth Control and Apoptosis Functions of Id Proteins
Norton, J. D., & Atherton, G. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2371 · Cited by 187
Marrogi, A. J., Munshi, A., Merogi, A. J., Ohadike, Y., El-Habashi, A., Marrogi, O. L., & Freeman, S. M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971021)74:5<492::aid-ijc3>3.0.co;2-z · Cited by 183
Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer.
Schindl, M., Oberhuber, G., Obermair, A., SCHOPPMANN, S. F., Karner, B., & Birner, P. (2001) · PubMed · Cited by 179
Yates, P. R., Atherton, G. T., Deed, R. W., Norton, J. D., & Sharrocks, A. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.968 · Cited by 152
Straume, O., & Akslen, L. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61688-4 · Cited by 151
Self-citationSchindl, M., SCHOPPMANN, S. F., Ströbel, T., Heinzl, H., Leisser, C., Horvat, R., & Birner, P. (2003) · PubMed · Cited by 150
Overexpression of Id‐1 is associated with poor clinical outcome in node negative breast cancer
Schoppmann, S. F., Schindl, M., Bayer, G., Aumayr, K., Dienes, J., Horvat, R., Rudas, M., Gnant, M., Jakesz, R., & Birner, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11009 · Cited by 141
Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis
Nakamoto, M., & Bergemann, A. D. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10177 · Cited by 138
Straume, O., & Akslen, L. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64922-x · Cited by 135
Self-citationId-1 Delays Senescence but Does Not Immortalize Keratinocytes
Nickoloff, B. J., Chaturvedi, V., Bacon, P., Qin, J.-Z., Denning, M. F., & Diaz, M. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000311200 · Cited by 128
Straume, O., Smeds, J., Kumar, R., Hemminki, K., & Akslen, L. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64174-0 · Cited by 124
Self-citationStraume, O., & Akslen, L. A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971021)74:5<535::aid-ijc10>3.0.co;2-5 · Cited by 124
Self-citationCzuwara-Ladykowska, J., Sementchenko, V. I., Watson, D. K., & Trojanowska, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200206200 · Cited by 116
The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
Polsky, D., Young, A. Z., BUSAM, K. J., & Alani, R. M. (2001) · PubMed · Cited by 116
Melanocytic Tumors of the Skin
Stern, J., Elder, D. E., & Murphy, G. F. (1994) · The American Journal of Dermatopathology · doi:10.1097/00000372-199408000-00017 · Cited by 113
Ling, M., Wang, X., Ouyang, X., Lee, T. K., Fan, T., Xu, K., Tsao, S., & Wong, Y. C. (2002) · Oncogene · doi:10.1038/sj.onc.1206007 · Cited by 107
Herlyn, M., Berking, C., Li, G., & Satyamoorthy, K. (2000) · Melanoma Research · doi:10.1097/00008390-200008000-00001 · Cited by 97
Molecular Regulation of Melanocyte Senescence
Bennett, D. C., & Medrano, E. E. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02036.x · Cited by 95
Id gene expression as a key mediator of tumor cell biology.
Israel, M. A., Hernandez, M., Florio, M., et al. (1999) · PubMed · Cited by 75
Cheung, H. W., Ling, M.-T., Tsao, S. W., Wong, Y. C., & Wang, X. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh087 · Cited by 68
Lee, K. T., Lee, Y. W., Lee, J. K., Choi, S. H., Rhee, P., Paik, S. S., & Kong, G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601684 · Cited by 62
Ets 1 is expressed in capillary blood vessels but not in lymphatics
Wernert, N., Okuducu, A. F., & Pepper, M. S. (2003) · The Journal of Pathology · doi:10.1002/path.1380 · Cited by 22
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Upregulation of EphA2 occurs in several cancers such as melanoma [157] , ovarian [158, 159] , prostate [160, 161] , lung [162, 163] , and breast [164, 165] cancer.”
BackgroundIsenberg, J. S., Martin-Manso, G., Maxhimer, J. B., & Roberts, D. D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2561 · Cited by 305
Metadata
- Authors
- Straume, O., & Akslen, L. A.
- Affiliations
- Haukeland University Hospital (NO)
- Corresponding author
- Akslen, L A
- Venue
- British Journal of Cancer
- Published
- 2005-09-27
- Volume
- 93
- Issue
- 8
- Pages
- 933-938
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2361652
- OpenAlex
- W2032702028
- Cited by
- 42
- References
- 41
- Citations by year
- 2024: 1 · 2021: 2 · 2020: 3 · 2018: 2 · 2017: 1 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Helse Vest
- Norges Forskningsråd
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- Id1, nodular melanoma, thrombospondin-1, ephrin-A1, EphA2, tumor thickness, patient survival, prognosis, BRAF mutation, p16, angiogenesis, microvessel density, tumor progression, bHLH transcription factors
- MeSH terms
- Cell Survival, Humans, Immunohistochemistry, Melanoma, Neovascularization, Pathologic, Prognosis, Skin Neoplasms, Biomarkers, Tumor, Up-Regulation, Disease-Free Survival, Thrombospondin 1, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Ephrin-A1, Ephrin-A2, Inhibitor of Differentiation Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.